Source: SEC

Neograft: Received $5M in Equity Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

Jon McGrath

CEO Approval Rating

82/100

Neograft is a medical device company that engages in developing cardiac technologies for the coronary artery bypass graft surgery.